Dimer Instruments
Stephen Minne is an accomplished entrepreneur and executive with extensive experience in the engineering and technology sectors, particularly within the pharmaceutical and medical device industries. Currently serving as Co-Founder and CEO of Dimer Instruments since 2024, Stephen leads the development of instruments that enhance real-time data monitoring and quality assurance in pharmaceutical manufacturing. Prior roles include Senior Vice President of Product Development and Design at Saluda Medical, Vice President of Engineering and Innovation at True Digital Surgery, and Chief Technology Officer at Wyatt Technology. Stephen's notable achievements also encompass leadership positions at Bruker and Veeco Instruments, where responsibilities spanned product development, business development, and revenue growth for multi-million dollar business units. Stephen holds a Ph.D. and MS in Electrical Engineering from Stanford University, complemented by a BS in Electrical Engineering from the University of Illinois Urbana-Champaign. Additionally, Stephen has served as a Consulting Assistant Professor at Stanford University.
This person is not in any teams
Dimer Instruments
Dimer Instruments designs and manufactures instruments that enable real-time data monitoring and quality assurance during the pharmaceutical manufacturing process. Our state-of-the-art technology supports pharmaceutical companies in achieving higher standards of product quality and consistency, and ultimately market success. Our flagship system provides analytical data that helps make informed decisions quickly. The system is designed to monitor critical quality attributes and process parameters, facilitating immediate process adjustments. Dimer Instrument’s’ software provides advanced data management tools that harness the power of big data, maintaining an accurate, compliant record of all process analytics, while at the same time providing a comprehensive dataset for future process development. In short, Dimer Instruments’ products are contributing to the advancement of pharmaceutical production by facilitating the understanding and optimization of protein development.